About Mylan
Mylan is a company based in Canonsburg (United States) founded in 1954 by Milan Puskar and Don Panoz. It operates as a Direct-to-Consumer (D2C). The company has 38,000 employees as of December 31, 2023. Mylan has completed 6 acquisitions, including Cold-EEZE, DPT Laboratories and Famy Care. Mylan offers products and services including Medicines.
- Headquarter Canonsburg, United States
- Employees 38000 as on 31 Dec, 2023
- Founders Milan Puskar, Don Panoz
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Viatris
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$589.35 M (USD), Debt – Conventional
May 23, 2018
-
Investors
Deutsche Bank
& 1 more
-
Employee Count
38000
as on Dec 31, 2023
-
Investments & Acquisitions
Cold-EEZE
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mylan
Mylan offers a comprehensive portfolio of products and services, including Medicines.
Quality medicines are provided for global patient access.
People of Mylan
Unlock access to complete
Unlock access to complete
Software Development Team
176 people
Leadership Team
83 people
Senior Team
55 people
Sales and Marketing
54 people
Head Team
44 people
Product Management Team
36 people
Finance and Accounting
28 people
Human Resources and Administration
27 people
Unlock access to complete
Funding Insights of Mylan
Investors in Mylan
Mylan has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Deutsche Bank and Teva Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Diversified banking and financial services are provided globally.
|
Locked | Locked | Locked | |
|
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals.
|
Locked | Locked | Locked |
Investor details for Mylan
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Mylan
Mylan has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Cold-EEZE, DPT Laboratories and Famy Care.
Investment portfolio details for Mylan
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Online gaming and gambling platform
|
Locked | Locked | 2010 | Locked | |
|
Provider of lozenges and syrup for cough and cold
|
Locked | Locked | 2000 | Locked | |
|
Contract development and manufacturing services for pharmaceutical APIs are provided.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Mylan
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Mylan
Detailed financials for Mylan
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mylan Comparisons
Peer comparison for Mylan
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Mylan
Detailed competitors of Mylan
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mylan
Complete news archive for Mylan
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mylan
Mylan was founded in 1954 and raised its 1st funding round 61 years after it was founded.
Mylan is headquartered in Canonsburg, United States. It is registered at Canonsburg, Pennsylvania, United States.
Scott A Smith is the current CEO of Mylan.
As of Dec 31, 2023, the latest employee count at Mylan is 38,000.
Mylan, integrated into Viatris, is dedicated to enhancing access to quality medicines. The company operates within the global healthcare sector, aiming to empower individuals to live healthier lives at every stage. Solutions are provided to ensure patients receive necessary medications when and where needed.
Mylan offers Medicines.
Mylan has made 6 acquisitions, including Cold-EEZE, DPT Laboratories, and Famy Care.
Mylan has 2 investors. Key investors include Deutsche Bank, and Teva Pharmaceuticals.